Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.7M Sell
82,803
-34,444
-29% -$8.65M 7.73% 3
2026
Q1
$24.4M Sell
117,247
-453
-0.4% -$99.7K 8.41% 3
2025
Q4
$27.2M Buy
117,700
+4,733
+4% +$1.08M 8.61% 3
2025
Q3
$24.8M Buy
112,967
+18,967
+20% +$4.29M 7.86% 3
2025
Q2
$20.6M Buy
94,000
+496
+0.5% +$98.2K 6.96% 3
2025
Q1
$17.8M Sell
93,504
-6
-0% -$1.3K 6.91% 3
2024
Q4
$20.5M Buy
93,510
+3,236
+4% +$662K 7.11% 3
2024
Q3
$16.8M Buy
90,274
+16,952
+23% +$3.09M 6.06% 3
2024
Q2
$14.2M Buy
73,322
+2,556
+4% +$470K 5.23% 5
2024
Q1
$12.8M Buy
70,766
+1,684
+2% +$281K 4.63% 5
2023
Q4
$10.5M Buy
69,082
+6,330
+10% +$887K 4.04% 5
2023
Q3
$7.98M Sell
62,752
-1,777
-3% -$238K 3.48% 5
2023
Q2
$8.41M Buy
64,529
+533
+0.8% +$60.9K 3.78% 6
2023
Q1
$6.61M Buy
63,996
+17,658
+38% +$1.71M 3.25% 6
2022
Q4
$3.89M Buy
46,338
+6,203
+15% +$613K 2.28% 17
2022
Q3
$4.54M Sell
40,135
-8,410
-17% -$1.06M 2.72% 10
2022
Q2
$5.16M Sell
48,545
-14,075
-22% -$1.76M 2.78% 7
2022
Q1
$10.2M Buy
62,620
+8,960
+17% +$1.38M 4.01% 3
2021
Q4
$8.95M Buy
+53,660
New +$9.18M 3.23% 5

Other funds holding AMZN

Altrafin AG's AMZN Position: Q2 2026 in Review

Altrafin AG reduced its Amazon (AMZN) stake by 29% in Q2 2026, selling an estimated $8.65M and leaving 82,803 shares worth $19.7M. The position accounts for 7.73% of the portfolio, ranked #3.

Altrafin AG first reported a position in AMZN in Q4 2021 and has held it in 19 quarters since. The position peaked at $27.2M in Q4 2025. 6,119 funds tracked by Wall St. Rank hold AMZN as of Q2 2026.

  • Altrafin AG held 82,803 shares of Amazon worth $19.7M as of Q2 2026.
  • Altrafin AG sold 34,444 Amazon shares in Q2 2026, an estimated $8.65M.
  • Amazon made up 7.73% of Altrafin AG's portfolio in Q2 2026, its #3 holding.
  • Altrafin AG first reported a position in Amazon in Q4 2021 and has held it in 19 quarters since.
  • Altrafin AG's Amazon position peaked at $27.2M in Q4 2025.
  • 6,119 funds tracked by Wall St. Rank held Amazon as of Q2 2026.

Based on Altrafin AG's 13F filing for Q2 2026, filed 15 Jul 2026.